Personalis, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Personalis, Inc. (PSNL) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $800.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-08-04
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $800.00K.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $3.10M.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $3.30M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-03-31 | $800.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $3.10M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $3.30M 10-Q · filed 2025-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |